XM does not provide services to residents of the United States of America.

U.S. STOCKS Dell, Hewlett Packard Enterprise, Accenture



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>BUZZ-U.S. STOCKS ON THE MOVE-Dell, Hewlett Packard Enterprise, Accenture</title></head><body>

Eikon search string for individual stock moves: STXBZ

The Day Ahead newsletter: https://refini.tv/3LI4BU7

The Morning News Call newsletter: https://refini.tv/3dKUyB8

The S&P 500 and the Nasdaq were on track to open higher on Thursday propelled by a rally in Nvidia, while investors assessed the recent economic data and commentary from Federal Reserve officials to firm up bets on interest rate cuts this year. .N


At 9:01 ET, Dow e-minis 1YMc1 were down 0.12% at 38,813. S&P 500 e-minis ESc1 were up 0.20% at 5,501.75, while Nasdaq 100 e-minis NQc1 were up 0.35% at 19,989.

The top three NYSE percentage gainers premarket .PRPG.NQ:
** Best Inc Adr BEST.K, up 14.8%
** Li Cycl Hldg Ord LICY.K, up 11.9%
** Benson Hill Ord BHIL.K, up 10.8%

The top three NYSE percentage losers premarket .PRPL.NQ:
** PJT Partners Inc PJT, down 22.7%
** Accel Entrt Cl A ACEL.K, down 18.5%
** Tortoise Mdsm Egy NTG, down 8.8%

The top Nasdaq percentage gainer premarket .PRPG.O:
** MGO Global Inc MGOL.O, up 159.6%

The top three Nasdaq percentage losers premarket .PRPL.O:
** Mustang Bio Inc MBIO.O, down 40%
** NLS Pharmaceutics Ag NLSP.O, down 25.7%
** Kaival Brands Innovations Group Inc KAVL.O, down 24.9%


** Super Micro Computer Inc SMCI.O: up 5.3% premarket

** Dell Technologies Inc DELL.N: up 3.8% premarket
BUZZ - Gain as Musk says firms to supply racks for xAI's supercomputer nL4N3II0NT


** SolarEdge Technologies Inc SEDG.O: down 7.8% premarket
BUZZ - Down after JPMorgan cuts PT on weak solar demand in Europe nL4N3II0PH


** Vanda Pharmaceuticals Inc VNDA.O: down 6.6% premarket
BUZZ - Rejects takeover offers; shares drop nL4N3II0PS


** Hewlett Packard Enterprise Co HPE.N: up 4.3% premarket
BUZZ - Shares rise as UK probes Juniper buyout deal nL4N3II0QX


** Bilibili Inc BILI.O: up 8.7% premarket
BUZZ - JPM ups Bilibili to 'overweight' on game success, ad growth nL4N3II0RK


** Accenture PLC ACN.N: up 8.8% premarket
BUZZ - Gains as annual revenue growth forecast tops estimates nL4N3II0PB


** Trevena Inc TRVN.O: up 4.4% premarket
BUZZ - Rises on positive preclinical results for experimental drug

nL4N3II0WQ


** Jazz Pharmaceuticals PLC JAZZ.O: down 2.4% premarket
BUZZ - Falls after tremor drug misses main goal in study nL4N3II0ZR


** Spirit Aerosystems Holdings Inc SPR.N: down 1.8% premarket
BUZZ - Benchmark downgrades Spirit Aerosystems on delays in Boeing takeout nL4N3II0ZB


(Compiled by Rajarshi Roy and Abhinav Parmar)

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.